About Patent Foramen Ovale
The pathophysiologic causes of patent foramen ovale (PFO) are related to the embryonic development of the heart. During fetal development, the foramen ovale allows blood to bypass the lungs since oxygenation occurs through the placenta. After birth, the increased pressure on the left side of the heart and decreased pulmonary pressure cause the foramen ovale to close. However, in some cases, if right-side heart pressure exceeds left-side pressure, the foramen ovale may reopen, leading to a right-to-left shunt.
Non-modifiable risk factors are risk factors that cannot be changed. Non modifiable risk factors for PFO include:
- Genetic factors: Certain genetic conditions may increase the likelihood of having a PFO.
- Age: PFO is more common in younger individuals.
Modifiable risk factors for PFO are not well-established. However, there are some associations worth noting:
- Pregnancy and hormone-related factors: Hormonal changes during pregnancy or the use of hormonal contraceptives may influence PFO development.
- Hypertension-related factors: High blood pressure may contribute to PFO formation.
It's important to note that while these factors may influence PFO development, they do not guarantee its occurrence. If you have concerns about PFO or its risk factors, it's best to consult with your healthcare professional for personalized advice.
The most common early symptoms of patent foramen ovale (PFO) include:
- Blurred vision
- Dizziness
As PFO progresses or becomes more severe, other symptoms may occur, including:
- Malaise
- Clumsiness
- Poor concentration
- Paresthesia (abnormal sensations)
- Strength deficits
- Paralysis of the lower limbs
- Bladder or bowel dysfunction
- Sexual dysfunction
- Skin marmorata: This is a condition where the skin appears marbled due to blood vessel dilation and contraction issues.
It's important to note that these symptoms can vary from person to person, and not everyone with PFO will experience all of them. If you suspect you have PFO or are experiencing any concerning symptoms, it's best to consult with your healthcare professional for an accurate diagnosis and appropriate management.
To diagnose patent foramen ovale (PFO), the following examinations, tests, and procedures are commonly performed:
- Contrast transcranial doppler tltrasonography (cTCD): This test uses ultrasound to detect the presence of a PFO by injecting a contrast agent into a vein and monitoring the passage of microbubbles through the heart.
- Transthoracic echocardiography (TTE): TTE uses sound waves to create images of the heart and can help visualize the structure and function of the heart, including the presence of a PFO.
- Contrast eransthoracic Echocardiography (cTTE): Similar to TTE, cTTE involves injecting a contrast agent to enhance visualization of blood flow and detect the presence of a PFO.
- Transesophageal echocardiography (TEE): TEE is an invasive procedure where a probe is inserted into the esophagus to obtain detailed images of the heart structures. It is particularly useful for evaluating atrial septal tumors or defects and determining the severity of a PFO.
To determine the stage or severity of PFO, the number of microbubbles in the left atrium at rest and after Valsalva action can be used to classify the Right-to-Left Shunt (RLS) into four grades:
- Grade 0: No shunt (no microbubble)
- Grade 1: Small shunt (1-10 microbubbles)
- Grade 2: Moderate shunt (11-30 microbubbles)
- Grade 3: Large shunt (>30 microbubbles or full of microbubbles in the left atrium)
It's important to consult with your healthcare professional for accurate diagnosis and assessment of PFO.
The goals of treatment for patent foramen ovale (PFO) are to reduce the risk of recurrent stroke and improve overall patient outcomes. Here are the different treatment options and how they work towards achieving these goals:
Medications:
- Antiplatelet medications: These drugs, such as aspirin or clopidogrel, help prevent blood clot formation and reduce the risk of stroke.
- Anticoagulant medications: These medications, like warfarin or direct oral anticoagulants, also prevent blood clot formation and are often used in specific cases where there is a higher risk of clotting.
Therapeutic procedures:
- Percutaneous closure: This procedure involves using a catheter to place a device, like a closure device or plug, to seal the PFO. It reduces the risk of recurrent stroke by preventing blood clots from passing through the PFO.
Health behavior changes:
- Lifestyle modifications: Adopting a healthy lifestyle can help reduce the risk factors associated with stroke, such as maintaining a healthy weight, regular exercise, following a balanced diet, managing blood pressure and cholesterol levels, quitting smoking, and reducing alcohol consumption.
Other treatments:
- Migraine management: Some studies suggest that PFO closure may be effective in reducing migraine frequency and severity in certain patients with migraines associated with PFO. However, this is still a topic of debate and further research is needed to establish its effectiveness.
It is important to note that treatment decisions should be made on an individual basis after consulting with a healthcare professional who can assess the patient's specific condition and recommend the most appropriate treatment approach. Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Other side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.